Navidea Biopharmaceuticals Inc (OTCPK:NAVB)
$ 0.001 0 (0%) Market Cap: 100,000.00 Enterprise Value: -2.50 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 0/100

Navidea Biopharmaceuticals, Inc. - Virtual Investor Fireside Chat Series Transcript

Jun 16, 2020 / 06:00PM GMT
Release Date Price: $3.56 (+9.88%)
Jenene D. Thomas
Jenene Thomas Communications, LLC - CEO

I would like to welcome you all to day 2 of our virtual investor fireside chat series. My name is Jenene Thomas, CEO of JTC team, and I will be your moderator and host for this event. The Virtual Fireside Chat series is being held June 15 through 17 this week. For the lineup and schedule of presenting companies, visit www.vifiresidechat.com. All the chats will have a video webcast replay available on this site as well as each presenting company's sites.

I am now pleased to be joined by our next chat by Jed Latkin, CEO, CFO and COO of Navidea Biopharmaceuticals. Navidea is listed on the NYSE American and trades under the ticker NAVB.

Just a couple of housekeeping items before we get started. During our discussion today, Jed will be making forward-looking statements. Please refer to the company's SEC filings and website for the latest information. Also following the moderated portion of this discussion, we will be taking questions from our participants, and we

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot